Get our Free Patent Expiration Newsletter

Serving leading biopharmaceutical companies globally:

Mallinckrodt
Baxter
Express Scripts
Merck
Moodys
McKinsey

Last Updated: January 17, 2020

DrugPatentWatch Database Preview

Parathyroid Hormone - Biologic Drug Details

Join the DrugPatentWatch Referral Program
Get access to a free drug patent landscape report or a free one-month subscription

« Back to Dashboard

Recent Clinical Trials for Parathyroid Hormone

Identify potential brand extensions & biosimilar entrants

SponsorPhase
Darlington Memorial HospitalPhase 3
Ministry of Defence, United KingdomPhase 3
Clinical Research and Trials Unit (Norfolk & Norwich University Hospital, UK)Phase 3

See all Parathyroid Hormone clinical trials

Recent Litigation for Parathyroid Hormone

Identify key patents and potential future biosimilar entrants

District Court Litigation
Case NameDate
Genentech, Inc. v. Pfizer Inc.2019-04-05
Genentech, Inc. v. Immunex Rhode Island Corp.2019-03-29
Genentech, Inc. v. Samsung Bioepis Co., Ltd.2018-09-04

See all Parathyroid Hormone litigation

PTAB Litigation
PetitionerDate
Pfizer, Inc.2017-05-19

See all Parathyroid Hormone litigation

Pharmacology for Parathyroid Hormone
Ingredient-typeParathyroid Hormone

Company Disclosures: US Patents for Parathyroid Hormone

These patents were extracted from company disclosures
Applicant Tradename Biologic Ingredient Dosage Form BLA Number Approval Date Patent No. Assignee Estimated Patent Expiration Status Orphan Source
Nps Pharms Inc NATPARA parathyroid hormone INJECTABLE;INJECTION 125511 001 2015-01-23   Start Trial Allelix BioPharmaceuticals Inc. (Ontario, CA) 2039-03-29 RX Orphan company
Nps Pharms Inc NATPARA parathyroid hormone INJECTABLE;INJECTION 125511 002 2015-01-23   Start Trial Allelix BioPharmaceuticals Inc. (Ontario, CA) 2039-03-29 RX Orphan company
Nps Pharms Inc NATPARA parathyroid hormone INJECTABLE;INJECTION 125511 003 2015-01-23   Start Trial Allelix BioPharmaceuticals Inc. (Ontario, CA) 2039-03-29 RX Orphan company
Nps Pharms Inc NATPARA parathyroid hormone INJECTABLE;INJECTION 125511 004 2015-01-23   Start Trial Allelix BioPharmaceuticals Inc. (Ontario, CA) 2039-03-29 RX Orphan company
>Applicant >Tradename >Biologic Ingredient >Dosage Form >BLA >Number >Approval Date >Patent No. >Assignee >Estimated Patent Expiration >Status >Orphan >Source

Patent Text Search: US Patents for Parathyroid Hormone

These patents were identified by searching patent claims

Supplementary Protection Certificates for Parathyroid Hormone

Supplementary Protection Certificate SPC Country SPC Expiration SPC Description
/2005 Austria   Start Trial PRODUCT NAME: CINACALCET ODER EIN PHARMAZEUTISCH AKZEPTABLES DERIVAT ODER SALZ DESSELBEN, INSBESONDERE CINACALCET-HYDROCHLORID; REGISTRATION NO/DATE: EU/1/04/292/001-012 20041022
2006 00028 Denmark   Start Trial
678 Luxembourg   Start Trial PRODUCT NAME: TOBRAMYCINE OU UN SEL PHARMACEUTIQUEMENT ACCEPTABLE QUI EN DERIVE. FIRST REGISTRATION: 20110725
1/2004 Austria   Start Trial PRODUCT NAME: LANREOTIDE
0210 Netherlands   Start Trial PRODUCT NAME: PEGVISOMANT; NATIONAL REGISTRATION NO/DATE: EU/1/02/240/002 20021115; FIRST REGISTRATION: EU EU/1/02/240/001 20021115
0722 Netherlands   Start Trial PRODUCT NAME: TOBRAMYCINE OF EEN FARMACEUTISCH AANVAARDBAAR ZOUT DAARVAN; REGISTRATION NO/DATE: C(2011)5394 20110720
>Supplementary Protection Certificate >SPC Country >SPC Expiration >SPC Description

Make Better Decisions: Try a trial or see plans & pricing

Serving leading biopharmaceutical companies globally:

Colorcon
Dow
Express Scripts
AstraZeneca
McKesson
Medtronic

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.